SCHEMBL519399

SCHEMBL519399

CC1(C)CNC(=O)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7307898 1.00
SCHEMBL23462594 0.75 CHRNA7 (0.35)
SCHEMBL2522735 0.75
SCHEMBL17827629 0.75
SCHEMBL16906153 0.73 SMN1; SMN2 (0.45)
SCHEMBL2284513 0.72
SCHEMBL11688014 0.72 CHRNA7 (0.33)
SCHEMBL25239019 0.72 LMNA (0.41)
SCHEMBL4454355 0.72
SCHEMBL16889120 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 206 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090184062-A1 METHOD FOR INHIBITING BIOFILM GROWTH PPG INDUSTRIES OHIO, INC. (US) 2009-07-23 US claimed
US-20250346592-A1 HETEROCYCLIC PAD4 INHIBITORS CELGENE CORPORATION 2025-11-13 US disclosed
EP-4585265-A2 HETEROARYL INHIBITORS OF PLASMA KALLIKREIN Takeda Pharmaceutical Company Limited (JP) 2025-07-16 EP disclosed
EP-4531849-A1 HETEROCYCLIC PAD4 INHIBITORS CELGENE CORPORATION (US) 2025-04-09 EP disclosed
WO-2025070770-A1 COMPOUND HAVING OXAZOLIDINE STRUCTURE, NONAQUEOUS ELECTROLYTE CONTAINING SAID COMPOUND, AND NONAQUEOUS ELECTROLYTE BATTERY CONTAINING SAID NONAQUEOUS ELECTROLYTE セントラル硝子株式会社 2025-04-03 WO disclosed
US-20250101041-A1 POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 VANDERBILT UNIVERSITY 2025-03-27 US disclosed
US-12116369-B2 Substituted pyrazolo[1,5-a]pyrimidines as glucocerebrosidase activators Bial—R&D Investments, S.A. (PT) 2024-10-15 US disclosed
US-12110294-B2 CD73 compounds GILEAD SCIENCES, INC. (US) 2024-10-08 US disclosed
US-20240294482-A1 METHOD FOR CATALYTICALLY ACTIVATING CARBON DIOXIDE AS CARBONYLATION REAGENT WITH INORGANIC SULFUR INNER MONGOLIA UNIVERSITY OF TECHNOLOGY (CN) 2024-09-05 US disclosed
US-20240228488-A1 HETEROARYL INHIBITORS OF PLASMA KALLIKREIN TAKEDA PHARMACEUTICALS CO (JP) 2024-07-11 US disclosed
WO-1998057940-A1 HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF SYNAPTIC PHARMACEUTICAL CORPORATION (US) 1998-12-23 WO disclosed
US-5776933-A Method of inhibiting protease E. R. SQUIBB & SONS, INC. (US) 1998-07-07 US disclosed
US-5760036-A ENZYME INHIBITORS OF RETROVIRAL PROTEASE FOR PREVENTION OF AIDS E. R. SQUIBB & SONS, INC. (US) 1998-06-02 US disclosed
US-5559256-A Aminediol protease inhibitors E. R. SQUIBB & SONS, INC. (US) 1996-09-24 US disclosed
EP-0580402-A2 Aminediol protease inhibitors E.R. SQUIBB & SONS, INC. (US) 1994-01-26 EP disclosed
EP-0146748-B1 ORGANOPHOSPHORUS COMPOUND, PROCESS FOR ITS PREPARATION AND INSECTICIDAL, MITICIDAL OR NEMATICIDAL COMPOSITION CONTAINING IT ISHIHARA SANGYO KAISHA, LTD. (JP) 1988-05-04 EP disclosed
US-4590182-A Organophosphorus compound and insecticidal, miticidal or nematicidal composition containing it ISHIHARA SANGYO KAISHA LTD. (JP) 1986-05-20 US disclosed
EP-0146748-A1 Organophosphorus compound, process for its preparation and insecticidal, miticidal or nematicidal composition containing it ISHIHARA SANGYO KAISHA, LTD. (JP) 1985-07-03 EP disclosed
US-4000293-A METHOD OF INHIBITING BACTERIAL GROWTH WITH CERTAIN SELECTED 3-CHLORO-2-OXAZOLIDINONES INTERX RESEARCH CORPORATION (US) 1976-12-28 US disclosed
US-3931213-A BACTERICIDE INTERX RESEARCH CORPORATION (US) 1976-01-06 US disclosed